HCA/VEGFR-2-IN-4
HCA/VEGFR-2-IN-4 (15b) is a dual-action indolinylbenzenesulfonamide inhibitor with potent activity against cancer-associated hCA IX/XII (Ki values in low nM range) and VEGFR-2 (IC50 = 0.811 μM) . It demonstrates antiproliferative effects in breast cancer cell models, supporting its investigation in oncology research for targeting tumor hypoxia and angiogenesis.
Product Specifications
Field of Research
Cardiovascular Research, Cardiovascular Research; Cell Biology, Metabolism Research, Signal Transduction
Molecular Formula
C22H23FN6O5S
Molecular Weight
502.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog